Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Solentim Ltd
Solentim Ltd
Activities:
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
Cell-based therapy specialist Solentim expands European operations
The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within the EU
Finance
Solentim expands operations to China
“This direct investment will help us support and expand our activities,” said General Manager of Solentim China, Kun Peng
Research & Development
Solentim launches workflow for single stem cell cloning
The company aims to create, isolate and characterise the highest value cells for biological medicine development
Manufacturing
Solentim names new Chief Marketing Officer
Dr Mark Truesdale will join the cell line development (CLD) instrumentation specialist
Pharmaceutical
Solentim and SAL Scientific partner on cell line development
Collaboration will add SAL’s new growth supplements for cell culture media to Solentim's offerings
Finance
Research funding round-up
Capital to support the development of new drugs and technology around the world
Manufacturing
Simple, single-use TFF solution for R&D or manufacturing
Solentim claims significant time-saving advantages are provided by its new systems
Subscribe now